BioNTech
Advancing science to transform cancer and infectious disease treatments
Mainz, Germany · Founded 2008 · $425.0M raised
- Headquarters
- Mainz
- Employees
- 5001–10000
- Founded
- 2008
- Business Model
- B2B
- Website
- biontech.com
- Total Funding
- $425.0M
- Last Round
- $425.0M Series AJan 2019
- Rounds
- 1
About
BioNTech is a global biotechnology company developing mRNA-based immunotherapies and vaccines for cancer and infectious diseases, leveraging immune engineering to translate science into survival.
Summary
BioNTech is a Biotech company based in Mainz, Germany, founded in 2008. It has raised $425.0M in total across 1 round, most recently a $425.0M Series A round in Jan 2019.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2019
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...